Properties (47)
Predicate | Object |
---|---|
gptkbp:instanceOf |
chemical compound
|
gptkbp:application |
potential pharmaceutical agent
|
gptkbp:built |
synthesis complexity
|
gptkbp:campusFacilities |
various universities
|
gptkbp:chemicalFormula |
thiazole derivatives
contains thiazole rings C12H14N2O4S |
gptkbp:clinicalTrials |
under investigation
|
gptkbp:collaborations |
pharmaceutical companies
|
gptkbp:colors |
white to off-white powder
|
gptkbp:compatibleWith |
inhibitor of certain enzymes
|
gptkbp:composedOf |
via thiazole derivatives
|
gptkbp:dissolved |
soluble in DMSO
|
gptkbp:distribution |
1.25 g/cm³
|
gptkbp:drugInterdiction |
moderate absorption
|
gptkbp:endOfLife |
4 hours
|
gptkbp:environmentalImpact |
low toxicity in vitro
|
gptkbp:financial_aid |
stable under normal conditions
|
gptkbp:funding |
grants from government agencies
|
gptkbp:future_plans |
clinical trials and development
|
https://www.w3.org/2000/01/rdf-schema#label |
WPC-952
|
gptkbp:iceClass |
150-155 °C
not determined |
gptkbp:impact |
none reported in studies
|
gptkbp:is_aimed_at |
cancer
|
gptkbp:isATypeOf |
123456-78-9
|
gptkbp:judgingCriteria |
HPLC
|
gptkbp:market |
not commercially available
|
gptkbp:nutritionalValue |
liver metabolism
|
gptkbp:origin |
N-(4-(2-(4-(dimethylamino)phenyl)thiazol-4-yl)thiazol-2-yl)phenyl)acetamide
|
gptkbp:patentCitation |
protected by patents
|
gptkbp:patentStatus |
patented
|
gptkbp:publications |
multiple peer-reviewed articles
|
gptkbp:regulatoryCompliance |
not approved for clinical use
|
gptkbp:related_to |
thiazole derivatives
|
gptkbp:releaseYear |
2010
|
gptkbp:research_areas |
medicinal chemistry
|
gptkbp:route |
multi-step synthesis
|
gptkbp:safety |
handle with care
|
gptkbp:safetyFeatures |
available
|
gptkbp:storage |
store in a cool, dry place
|
gptkbp:team |
2.5
|
gptkbp:triggerType |
enzyme inhibition
|
gptkbp:trimLevels |
neutral
|
gptkbp:uses |
research chemical
|
gptkbp:waterManagement |
urinary excretion
|
gptkbp:weight |
278.32 g/mol
|